Best Practices for Selecting a Predicate Device to Support a Premarket Notification [510(k)] Submission

This guidance provides recommendations to industry and FDA staff about the best practices of choosing a predicate device for a 510(k) submission. A 510(k) is a premarket submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device (section 513(i)(1)(A) FD&C Act).

This guidance provides recommendations to industry and FDA staff about the best practices of choosing a predicate device for a 510(k) submission. A 510(k) is a premarket submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device (section 513(i)(1)(A) FD&C Act).
September 7, 2023

Yesterday, the FDA released the draft guidance “Best Practices for Selecting a Predicate Device to Support a Premarket Notification [510(k)] Submission” This comprehensive document offers valuable insights and recommendations to streamline the premarket notification process, ensuring that medical device manufacturers select appropriate predicate devices for their submissions.

The premarket notification 510(k) process, commonly referred to as 510(k), is a regulatory pathway overseen by the FDA for the approval of medical devices. It requires MedTech manufacturers to demonstrate that their new device is substantially equivalent to an existing “predicate” device already on the market in terms of safety and effectiveness. It enables manufacturers to bring their products to market efficiently, thereby saving both time and costs compared with more extensive regulatory pathways.

For any questions, you can contact our team of MedTech experts: medtech@asphalion.com

Or schedule a free 30-minutes meeting here: https://bit.ly/3NwVsNR

 

Search News & Events

  • Filter by category

Share

Related news and events

NEWS | New Insight on the Implementation of MDR Article 17

Article 17 of Regulation (EU) 2017/745 (Medical Device Regulation – MDR) regulates the reprocessing of single-use devices (SUDs) with relevance for the European Economic Area (EEA) which may only take place where permitted by national law and in accordance with this article.

New opening! | Pamplona office

At Asphalion, we are thrilled to announce the opening of our new office in Pamplona! This strategic decision reflects our commitment to being closer to

The European Union’s AI Act & its Impact on Medical Devices

The AI Act (AIA) is the EU’s first attempt to create a comprehensive AI regulatory framework and aims to ensure the protection of fundamental rights in this field. AI applications used in healthcare are often ‘medical devices’ and are thus regulated under the EU Medical Devices Regulation (MDR).

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting